17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation

被引：50

作者：

Dijkstra, M. K. ^{[1
]}

van Lom, K. ^{[1
]}

Tielemans, D. ^{[2
]}

Elstrodt, F. ^{[3
]}

Langerak, A. W. ^{[2
]}

van't Veer, M. B. ^{[1
]}

Jongen-Lavrencic, M. ^{[1
]}

机构：

[1] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands

[2] Erasmus Univ, Med Ctr, Dept Immunol, Rotterdam, Netherlands

[3] Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Med Oncol, Rotterdam, Netherlands

来源：

LEUKEMIA | 2009年 / 23卷 / 03期

关键词：

TUMOR-SUPPRESSOR;

D O I：

10.1038/leu.2008.264

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：625 / 627

页数：4

共 8 条

[1] p53-mediated activation of miRNA34 candidate tumor-suppressor genes [J].

Bommer, Guido T. ;

Gerin, Isabelle ;

Feng, Ying ;

Kaczorowski, Andrew J. ;

Kuick, Rork ;

Love, Robert E. ;

Zhai, Yali ;

Giordano, Thomas J. ;

Qin, Zhaohui S. ;

Moore, Bethany B. ;

MacDougald, Ormond A. ;

Cho, Kathleen R. ;

Fearon, Eric R. .

CURRENT BIOLOGY, 2007, 17 (15) :1298-1307

[2] CD38 as a prognostic factor in BCeH chronic lymphocytic leukaemia (B-CLL): Comparison of three approaches to analyze its expression [J].

Boonstra, JG ;

van Lom, K ;

Langerak, AW ;

Graveland, WJ ;

Valk, PJM ;

Kraan, J ;

van 't Veer, MB ;

Gratama, JW .

CYTOMETRY PART B-CLINICAL CYTOMETRY, 2006, 70B (03) :136-141

[3] Mechanisms of disease: Chronic lymphocytic leukemia [J].

Chiorazzi, N ;

Rai, KR ;

Ferrarini, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08) :804-815

[4] Genomic aberrations and survival in chronic lymphocytic leukemia. [J].

Döhner, H ;

Stilgenbauer, S ;

Benner, A ;

Leupolt, E ;

Kröber, A ;

Bullinger, L ;

Döhner, K ;

Bentz, M ;

Lichter, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1910-1916

[5] BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants [J].

Elstrodt, F ;

Hollestelle, A ;

Nagel, JHA ;

Gorin, M ;

Wasielewski, M ;

van den Ouweland, A ;

Merajver, SD ;

Ethier, SP ;

Schutte, M .

CANCER RESEARCH, 2006, 66 (01) :41-45

[6] Assessing TP53 status in human tumours to evaluate clinical outcome [J].

Soussi, T ;

Béroud, C .

NATURE REVIEWS CANCER, 2001, 1 (03) :233-240

[7]

van't Veer MB, 2006, HAEMATOLOGICA, V91, P56

[8] MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells [J].

Welch, C. ;

Chen, Y. ;

Stallings, R. L. .

ONCOGENE, 2007, 26 (34) :5017-5022

← 1 →